Murray hits FDA for its delay on morning-after pill
By Alicia Mundy
Seattle Times Washington bureau
WASHINGTON — U.S. Sen. Patty Murray has accused the Food and Drug Administration of using a double standard to delay a decision over whether the emergency-contraceptive drug Plan B should be sold over-the-counter...
Click here to read the rest of this article.
|
